Program for all days

Better Kidney Health

The Interconnected Kidney

Preserving Kidney Health

The Smart Kidney

Plenary Sessions

WCN Courses

Spotlight Sessions

Special Sessions

Global Kidney Policy Forum

Welcome Reception

Topical Networking

Poster Sessions

Industry Symposia

Friday, April 2, 2027

Time	Session

09:15 10:45	HIT Session 1 Ballroom 1								Rare Kidney Disease Registries: From Patient Data to Drug Development How have rare kidney disease registries transformed clinical development? Laura Mariani Speaker From registry to regulatory evidence: how RaDaR works Danny Gale Speaker Building a national disease registry: lessons from the Japanese Paediatric Alport Syndrome Registry Tomohiko Yamamura Speaker Q&A Ballroom 2								Nephroprotection in CKD: From Mechanisms to Guideline-directed Treatment and Equitable Access Translational Benefits of Four‑Pillar Combination Therapy in CKD David Wheeler Speaker Integrating Trial Evidence and Combination Therapy into CKD Guidelines Magdalena Madero Speaker When evidence outpaces access: Challenges in applying GDMT in low-resource settings Vivek Jha Speaker Q&A Conference Hall 2								The Kidney in Cancer Care: Navigating Increasingly Complex Clinical Challenges Beyond the formula - rethinking kidney function in cancer care Jennifer Lees Speaker Anemia at the crossroads of CKD and cancer Kenar Jhaveri Speaker Treating MGRS: Are We Shifting to an Induction and Maintenance Paradigm Q&A Banquet Hall								The Changing Landscape of Inflammation and Anaemia in CKD Inflammation, hepcidin and iron-restricted erythropoiesis: the molecular axis Kai-Uwe Eckardt Speaker Targeting IL-6 in CKD anaemia: ziltivekimab, RESCUE and the road to ZEUS Vlado Perkovic Speaker HIF stabilisers in the real world after the 2026 KDIGO update Manisha Sahay Speaker Q&A Plenary Theatre								Kidney Aging, Repair and Regeneration: From Disease Mechanisms to Future Therapies Failed Repair as a Driver of Kidney Aging and CKD Progression From Cellular Senescence to Tertiary Lymphoid Structures: Mechanisms of Failed Kidney Repair Motoko Yanagita Speaker Targeting Regulated Cell Death for Kidney Repair Andreas Linkermann Speaker Q&A Conference Hall 1								ISN-PKD Foundation Conference Hall 3								ISN-Lancet Joint Session: Making CKD Visible — Lessons From The Lancet CKD Series Precision in CKD Diagnosis: Are We Diagnosing Kidney Disease Accurately in Everyone Luxia Zhang Speaker Sex, Gender and CKD: The Missing Dimension in Kidney Health Jennifer Lees Speaker Kidney health for all: How can we improve equity in CKD care Lori-Ann Fisher Speaker Q&A 408+409								Big Data Lab 406+407
11:30 12:30	Plenary Session 2 Ballroom 1
14:00 15:30	Complement-mediated Kidney Diseases: From Mechanism to Treatment Complement genetics and autoantibodies as drivers of kidney disease David Kavanagh Speaker Complement driven kidney injury "in and out" of the glomerulus Richard Lafayette Speaker Blocking complement activation to preserve kidney function-where are we in 2027? Hernan Trimarchi Speaker Q&A Ballroom 1								Hypertension: Innovations in Diagnosis and Management Is it truly “resistant”? Measurement and adherence checks as essential tools in treating the patient with hypertension Swapnil Hiremath Speaker New treatments and when to introduce them in a patient’s regimen Pediatric patients with hypertension: will they benefit from innovations? Rahul Chanchlani Speaker Q&A Ballroom 2								Kidney Care in Times of Crisis: Disaster Preparedness and Sustainability The dialysis unit in natural disasters: practical tips for managing patients with ESKD Lori-Ann Fisher Speaker Perspectives on kidney health in man-made disasters: conflict, displacement, and infrastructure failure Ali Abu-Alfa Speaker Translating Lessons Learnt from Disasters to Evidence and Policy Q&A Conference Hall 2								Atrial Fibrillation in Kidney Disease: Risk Assessment, Anticoagulation and Device-based Interventions Calculating risk, changing care: risk prediction and its implications in CKD/ESKD Anticoagulation in atrial fibrillation and kidney disease: a decision without an easy answer Wolfgang Winkelmayer Speaker An alternative to anticoagulation? Left atrial appendage devices and their risk-benefit in kidney disease Lim Choon Pin Speaker Q&A Banquet Hall								AI and Xenotransplantation: Can Emerging Technologies Disrupt Access to Kidney Transplantation? Xenotransplantation: a real answer to the donor shortage? Living-donor program models that have expanded access Rosnawati Yahya Speaker Can AI widen access? Donor-recipient matching, allocation and post-transplant monitoring Q&A Plenary Theatre								Genetic Testing in CKD: Are We Ready for Precision Nephrology? Clinical utility of genetic testing in nephrology Becky Ma Speaker Genetic testing for CKD – Should we go broad or indication-based? Roser Torra Speaker Implementation of genetic testing in nephrology – a global landscape Andrew Mallett Speaker Mainstreaming clinical genetic testing in resource-limited settings Mythri Shankar Speaker Q&A Conference Hall 1								Clinical Trials in Kidney Disease: Challenges, Innovations and Future Directions Evolving clinical trial endpoints: The place of hierarchical endpoints Hiddo Heerspink Speaker Platform tries in kidney disease-Are we any further ahead? Meg Jardine Speaker How do we improve participation of underserved populations in clinical trials? David Wheeler Speaker Where are we with measuring patient reported outcomes in trials in kidney disease? Priya Vart Speaker Evolving with success and working with regulators: Redesigning clinical trials in IgAN trials Brad Rovin Speaker Q&A Conference Hall 3								KL Case Reports 408+409								Advocacy Session: From Resolution to Reality: The Kidney Health Implementation Journey 406+407
16:15 17:15	Celebrating a Decade of the ISN-Global Kidney Health Atlas and Exploring New Insights From the 2027 Edition A Decade of Data: What the ISN-GKHA Has Taught Us (2016–2027) David Johnson Speaker From Global Evidence to Global Action: Using the ISN-GKHA to Implement the WHO Kidney Health Resolution Aminu Bello Speaker Next Steps and Future Adeera Levin Speaker Q&A Ballroom 1									GREEN-K: A Patient-centered Sustainable Procurement Strategy Introducing the GREEN-K joint statement on procurement (JSP) Vivek Jha Speaker Applications of the JSP in low and low middle income countries (LLMICs) Magdalena Madero Speaker Using the GREEN-K toolkit to support operationalizing the JSP Winston Fung Speaker Q&A Ballroom 2									Hot Debate: Is Risk-Stratified Screening Enough to Address the Global CKD Burden? Motion: “This house believes that risk-stratified CKD screening is inadequate to address the global CKD burden.” Opposition Motion: “This house believes that risk-stratified CKD screening is inadequate to address the global CKD burden.” Proposition Vivek Jha Speaker Q&A Conference Hall 2									Hot Debate: To Treat or Not to Treat — Debating Guideline-directed Therapy in CKD Patients With Frailty and Multimorbidity For aggressive GDMT Odutayo Ayodele Speaker Against aggressive GDMT June Fabian Speaker Q&A Banquet Hall									Hot Debate: Should Peritoneal Dialysis Be the Default First-line Therapy in Low-resource Settings? The case for a PD-First default in LMIC/LIC settings The case against a mandated PD-First default Gloria Ashuntantang Speaker Q&A Plenary Theatre									World Kidney Day 2027 Joint Session: Kidneys, Heart and Metabolism — the Core of Your Health Kidneys, Heart, and Metabolism: The Core of Your Health Kidneys, Heart, and Metabolism: The Core of Your Health Ricardo Correa Rotter Speaker Q&A Conference Hall 1									ISN-WIN Joint Session: Bridging the Gaps for Women in Kidney Health The road less travelled - women in academic nephrology Jia Ng Speaker Women representation in clinical research Rathika Krishnasamy Speaker Pr-AKI - from global snapshot to one village at a time Nzana Victorine Bandolo Speaker Q&A Conference Hall 3									PLAG Session: Kidney Care Through Patients' Eyes: Lessons from Malaysia 408+409

Saturday, April 3, 2027

Time	Session

08:00 09:00	ISN-KI/KIR/KICR 406+407
09:15 10:45	HIT Session 2 Ballroom 1																																			Targeted Therapies for Genetic Kidney Diseases: The New Era Taking advances in genetic understanding to delivery of new therapies: The APOL1 story Rasheed Gbadegesin Speaker RNA therapeutics for kidney disease: from gene silencing to the clinic Jonathan Barratt Speaker Can we deliver gene therapy to the kidney? Rachel Lennon Speaker Q&A Ballroom 2																																			Tropical Infections and AKI: Prevention, Diagnosis and Management AKI epidemiology and management approaches in tropical infections Lily Mushahar Speaker AKI in pandemics: lessons learned from Ebola and COVID-19 Yannick Nlandu Speaker AKI in Leptospirosis: From Diagnosis to Management Vin-Cent Wu Speaker Q&A Conference Hall 2																																			Complement and the Glomerulonephritides: Where Do the New Drugs Fit in Clinical Practice? Complement-driven kidney injury: mechanisms inside and outside the glomerulus. ANCA Vasculitis After Avacopan: What Role for Complement Inhibition Remains Michael Walsh Speaker IgA Nephropathy: A Crowded Pipeline of Options and the Role of Complement Inhibition Sydney Tang Speaker Q&A Banquet Hall																																			Precision Renal Pathology: From AI-Assisted Analysis to Molecular Classification Artificial Intelligence in Renal Pathology: Repeated Biopsies and the Biopsy Report of the Future Peter Boor Speaker Beyond Histology: How molecular biopsy analysis and the Kidney Precision Medicine Project can guide treatment Matthias Kretzler Speaker Genetics, metabolomics, and histology: the future of integrative diagnosis, understanding and treatment of kidney disease Katalin Susztak Speaker Q&A Plenary Theatre																																			ISN-YNC Joint Session: The Future Nephrologist — AI, Genomics and the Next Decade in Kidney Care Artificial Intelligence in Kidney Care: From Predictive Algorithms to Precision Treatment Ping Liu Speaker The Genomic Revolution in Nephrology: What Every Nephrologist Needs to Know about implementation and interpretation Janewit Wongboonsin Speaker Q&A Conference Hall 1																																			ISN-KDIGO Joint Session: What's New in CKD and Diabetes Guidelines? Translating Successes in Trials to Better Outcomes in Patients: Takeaways from the 2027 CKD Guideline Adeera Levin Speaker Implementing CKM Therapeutics: Slow n' Easy or Fast n' Furious? Christopher Wanner Speaker CKD Prevention in Diabetes: Yes, We Can! Peter Rossing Speaker Strategies for Improving Guideline-Directed Medical Therapies Adherence: An Asian Perspective Sunita Bavanandan Speaker Q&A Conference Hall 3																																			ISN-KI/KIR/KICR 408+409																																			ISN i3C (CKDu) Exchange Session The CKDx Framework: Advancing the Classification of Kidney Diseases Without a Diagnosis Tubulointerstitial Diseases: A Framework for Diverse and Emerging Entities CKDu: One Disease, Multiple Definitions, More Than One Disease? Exploring Its Diversity and Diagnostic Challenges Debate: Heat Stress Nephropathy vs. Heat-Exacerbated Kidney Disease: How Should We Describe the Impact of Heat on Kidney Health? Debate: Heat Stress Nephropathy vs. Heat-Exacerbated Kidney Disease: How Should We Describe the Impact of Heat on Kidney Health? Q&A 406+407
11:30 12:30	Plenary Session 3 Ballroom 1
14:00 15:30	HIT Session 3 Ballroom 1																																													Beyond Rituximab: Evolution in B Cell-targeted Therapies for Glomerular Diseases Beyond the usual suspects: discovery of pathogenic antibodies in kidney disease Tobias Huber Speaker Beyond Rituximab: The evolution of B Cell Directed Therapies in Glomerular Disease Beyond rituximab: the next generation of B-cell-directed therapy Adrian Liew Speaker Q&A Ballroom 2																																													ISN-EASD Joint Session: Advances in Diabetes Technology and Managing Diabetes in End Stage Kidney Disease Automated Insulin Delivery for Patients with Kidney Failure Smart-Phone Based Application to Treat Diabetic Kidney Disease Update of Pharmacological Therapy of Diabetic Kidney Disease Q&A Conference Hall 2																																													Globally Deliverable Lifestyle Interventions Across the CKD Journey Emerging paradigms for dietary management of CKD Jessica Dawson Speaker Self-management in practice: blood pressure, medicines and lifestyle in low-resource settings Robert Kalyesubula Speaker Renal rehabilitation at scale: the Japanese experience Masahiro Kohzuki Speaker Q&A Plenary Theatre																																													ISN-YNC Joint Session: The Future of Nephrology: How Is AI Reshaping Training and Clinical Practice? Large Language Models for Kidney Disease Diagnosis: Lessons from a Randomized Controlled Trial Sola Aoun Bahous Speaker Artificial intelligence in hypertension and dialysis care: can we personalize care? Conor Judge Speaker AI in Nephrology Education: Lessons from Malaysia and Around the World Fadhlina Zakaria Speaker Q&A Conference Hall 1																																													Kidney Health in Pregnancy: Treating Our Most Vulnerable Kidney Patients Pregnancy Risk and Management in Advanced Chronic Kidney Disease (CKD) Michelle Hladunewich Speaker Minimizing Risk and Managing Pregnancy in Women on Dialysis Alejandra Orozco Guillen Speaker Optimizing Pregnancy Outcomes in Renal Transplant Recipients Shilpa Jesudason Speaker Q&A Conference Hall 3																																													ISN-DICG Joint Session: Organ Shortage, Trafficking and Donor Incentives Singapore is a hot spot for transplant tourism Recommendations for ethical incentives in organ donation Thomas Mueller Speaker Organ and human trafficking in South-East Asia Q&A 408+409
16:15 17:15	ISN-MSN Joint Session: What Can the ISN Global Kidney Health Atlas Tell Us About Kidney Health in Malaysia? Ballroom 1																																																															ISN-IPNA Ballroom 2																																																															AKI and AKD: Rethinking Classification and Management Revisiting the New AKI/AKD Framework: Latest Evidence on Prevention from KDIGO AKI-D: Managing Acute Dialysis When Recovery is Possible Chi-Yuan Hsu Speaker Q&A Conference Hall 2																																																															Hot Debate: Renal Denervation on Trial — a Case-based Debate on Resistant Hypertension Against renal denervation Swapnil Hiremath Speaker For renal denervation Jiguang Wang Speaker Q&A Banquet Hall																																																															Hot Debate: Potassium-containing Salt Substitutes in CKD — Cardiovascular Benefit or Hidden Risk? Salt substitutes in CKD: the benefit case, including selective use Salt substitutes in CKD: the caution case — hyperkalaemia risk Sunita Bavanandan Speaker Q&A Plenary Theatre

Sunday, April 4, 2027

Time	Session

09:15 10:45	HIT Session 4 Ballroom 1				Global Disparities in Rare Kidney Diseases: Challenges and Solutions How do we write guidelines that are fit for a global audience when access to drugs is so varied? Hernan Trimarchi Speaker Pragmatic trials of affordable treatments in resource-limited settings Suceena Alexander Speaker Global patient involvement to find solutions for rare kidney diseases Susie Gear Speaker Q&A Ballroom 2				Can Emerging Dialysis Technologies Reduce the Environmental Impact of Kidney Care? Water-conserving portable peritoneal and haemodialysis systems in development Azrul Azlan Hamzah Speaker Wearable peritoneal dialysis: from prototype to patient Abdul Halim Abdul Gafor Speaker Sorbent-based portable haemodialysis: where the technology stands Karin Gerritsen Speaker Q&A Conference Hall 1				PKH6: Will New Technologies Help Achieve Sustainable Kidney Care? Conference Hall 1				When Kidney and Placental Health Intersect: Mechanisms, Biomarkers and Global Burden The Kidney’s Role in Abnormal Placentation S Ananth Karumanchi Speaker Angiogenic Biomarkers in Practice: sFlt-1/PlGF in the CKD Population Michelle Hladunewich Speaker The Global Burden of Preeclampsia and Preterm Birth Robert Kalyesubula Speaker Q&A 406+407
11:00 12:00	Advances in Molecular Therapeutics for Kidney Diseases Gene editing in the kidney Danny Gale Speaker Small molecules to treat genetic kidney diseases Q&A Ballroom 1					ISN-ISPD Ballroom 2					ISN-EFIM Joint Session: Improving outcomes for cardio-renal/kidney metabolic health Conference Hall 1					ISN-Ethics Joint Session: Ethical Decision-making in Genetic Testing and Kidney Transplantation Genetic testing in kidney disease - ethical considerations and recommendations for practice Heather Gardiner Speaker Managing uncertainty in kidney transplantation - ethical considerations and recommendations for practice Dominique Martin Speaker Q&A 406+407
12:10 13:10	Plenary Session 4 Ballroom 1

Thursday, April 1, 2027

Time	Session

08:30 10:30	Annual Review of Nephrology Course Session 1 Translating Population-Level Data into Personalized Care for Chronic Kidney Disease Hiddo Heerspink Speaker Managing Severe Hyponatremia in the ESKD Patient: The Complex Role of Renal Replacement Therapy Sola Aoun Bahous Speaker Precision Blood Purification: Timing, Biomarkers, and Patient Selection for Hemoadsorption Therapies Claudio Ronco Speaker Q&A Ballroom 2	Renal Pathology Course Session 1 Podocytopathies- Focal Segmental Glomerulosclerosis – A global update Spectrum of FSGS lesions: Mechanistic implications Agnes Fogo Speaker Diversity of Podocytopathies in Africa Progress in diagnosis of Inherited Podocytopathies Paola Romagnani Speaker Digital biomarkers and artificial intelligence applications in podocytopathies Laura Barisoni Speaker Q&A Conference Hall 2	Interventional Nephrology Course Session 1 Point-of-Care Ultrasound (POCUS): Essential Skills for the Interventional Nephrologist Suryati Yakob Speaker VExUS Assessment: Clinical Applications in Kidney Disease Q&A Hands-On Banquet Hall	Onco-Nephrology Course Session 1 Proteinuria in the cancer patient Vascular Endothelial Growth Factor (VEGF) inhibitors and Tyrosine Kinase Inhibitors (TKI) toxicities Rajeevalochana Parthasarathy Speaker Paraneoplastic syndromes: contemporary understanding of ill-defined entities Monoclonal Gammopathies of Renal Significance (MGRS): Facts and Controversies Case-based Discussion Sabine Karam Speaker Q&A Plenary Theatre	Conservative Kidney Management Session 1 Introduction to the principles of and evidence for Conservative Kidney Management (CKM) Sara Davison Speaker Planning for conservative kidney management - international case studies Fadhlina Zakaria Speaker Essential communication skills for successful shared decision making Rafidah Abdullah Speaker Q&A Conference Hall 1	Allied Health Professionals Course Session 1 CKD Management Early CKD Detection and Prevention Soo Kun Lim Speaker Nutritional Strategies for CKD Progression Lau Wai Pooi Speaker Optimizing Pre-Dialysis Care: GDMT in Action Chuang Shen Hui Speaker Empowering Choice: Navigating Treatment Options Rachael Walker Speaker Q&A Conference Hall 3	Clinical Trials Course Session 1 408+409	Share RR Session 1 406+407
11:00 13:00	Annual Review of Nephrology Course Session 2 From Broad Immunosuppression to Precision Medicine: Redefining the Standard of Care in IgA Nephropathy Juergen Floege Speaker The Frontier of Cell Therapy in Refractory Lupus Nephritis Decoding the Complement Cascade in Kidney Disease Q&A Ballroom 2	Renal Pathology Course Session 2 Native & transplant kidney pathology – Advances/update Spectrum of toxic nephropathies in the tropical countries Kumari Hemlata Speaker Histologic Indices, Molecular diagnostics and the Banff Classification: Recent advances in Kidney Transplant Pathology Mark Haas Speaker Utility of kidney biopsy testing towards Precision medicine Joris Roelofs Speaker Making the most of the kidney biopsy tissue – A pathologist’s challenge Geetika Singh Speaker Q&A Conference Hall 2	Interventional Nephrology Course Session 2 Ultrasound-Guided Native Kidney Biopsy: Technique and Safety Haridian Sosa Barrios Speaker Fluoroscopy-Free Tunneled Hemodialysis Catheter Placement Bernardo Moguel Speaker Q&A Hands-On Banquet Hall	Onco-Nephrology Course Session 2 Contemporary prevention and management of drug toxicities in the Cancer Patient Platinum Toxicity: From Established Mechanisms to Emerging Strategies Maria Jose Soler Speaker New Insights on Immune Checkpoint Inhibitors (ICI) toxicities Sandra Herrman Speaker Glomerular Filtration Rate in the cancer patient: New Evidence and Clinical Implication Veronica Torres Costa Silva Speaker Case-based Discussion Q&A Plenary Theatre	Conservative Kidney Management Session 2 An introduction to symptoms in people with advanced chronic kidney disease Chenlei (Kelly) Li Speaker Management of restless legs, and CKD-associated itch in CKM Chenlei (Kelly) Li Speaker Management of pain in CKM Management of mental health problems in CKM Q&A Conference Hall 1	Allied Health Professionals Course Session 2 Dialysis & Symptom Management Managing PD from Nursing Perspective Norashikin Binti Mohd Izan Speaker Symptom Assessment and Management in Dialysis Ana Elizabeth Figueiredo Speaker Unpill the Burden: Navigating Polypharmacy and Adherence in Dialysis Jaime Chan Yoke May Speaker Overcoming Dietary Hurdles in Dialysis Fang Teong Lee Speaker The importance of sleep assessment and management in dialysis Ginger Chu Speaker Q&A Conference Hall 3	Clinical Trials Course Session 2 408+409	Share RR Session 2 406+407
13:45 15:45	Annual Review of Nephrology Course Session 3 Breaking the Barrier: The Immunological Frontier of Genetically Engineered Xenotransplantation Operationalising Genetic Testing in Nephrology: Practical lessons for developing countries Janewit Wongboonsin Speaker Aldosterone Synthase Inhibitors, Gene Silencing and Device Therapy in Resistant Hypertension and CKD Q&A Ballroom 2	Renal Pathology Course Session 3 Clinical-Pathologic Correlation Case Presentations Clinical-Pathologic Correlation Case Presentations - Case Discussant KAR WAH FUAH Speaker Clinical-Pathologic Correlation Case Presentations - Case Presentation Geetika Singh Speaker Kalyanasundaram Anusha Speaker Laura Barisoni Speaker Marek Kollar Speaker Mark Haas Speaker Surya Seshan Speaker Q&A Conference Hall 2	Interventional Nephrology Course Session 3 Peritoneal Dialysis Catheter Placement: Best Practices and Tips Sourabh Sharma Speaker Endovascular Interventional Nephrology & Arteriovenous Fistula (AVF) Assessment Ru Yu Tan Speaker Q&A Hands-On Banquet Hall	Onco-Nephrology Course Session 3 Onco-nephrology in special populations Onco-Nephrology in Kidney Transplant Recipients: Navigating Cancer and Graft Function AKI After Hematopoietic Stem Cell Transplantation: Mechanisms and Management Pediatric Onco-Nephrology: Unique Challenges and Emerging Perspectives - Gerrit Van Der Berg (M, Netherlands) Onco-nephrology Jeopardy Q&A Plenary Theatre	Conservative Kidney Management Session 3 Management of nausea and vomiting in CKM Nicola Wearne Speaker Managing the metabolic complications of kidney failure in CKM Sara Davison Speaker Transitioning near the end of life – care of the dying CKM patient including symptomatology in this period Chenlei (Kelly) Li Speaker Panel Discussion: The Full Scope of CKM and Why It Is Everybody's Business Fadhlina Zakaria Moderator Q&A Conference Hall 1	Allied Health Professionals Course Session 3 Conservative Kidney Management & Quality of Life Overview of Conservative Care in Malaysia Fadhlina Zakaria Speaker Comfort first: Prescribing & Deprescribing in Advance CKD Mui Hian Sim Speaker Practical Nutrition for Quality of Life in CKM Jessica Dawson Speaker Whole-person Care: Psychosocial Needs & Advance Care Planning Marques Shek Nam Ng Speaker Q&A Conference Hall 3	Clinical Trials Course Session 3 408+409	Global Kidney Policy Forum 406+407
16:00 17:30	WCN'27 Opening Ceremony and Plenary Session 1 Ballroom 1